BSE Live
Jan 16, 16:01Prev. Close
1409.40
Open Price
1401.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 16, 15:58Prev. Close
1410.20
Open Price
1409.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Dr Lal PathLabs (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 54.63 | 53.68 | 3.36 | 3.35 | 3.39 | |
| Total Share Capital | 81.26 | 80.31 | 5.02 | 5.02 | 5.06 | |
| Reserves and Surplus | 237.98 | 135.49 | 146.83 | 107.01 | 87.55 | |
| Total Reserves and Surplus | 237.98 | 135.49 | 146.83 | 107.01 | 87.55 | |
| Total Shareholders Funds | 319.24 | 215.80 | 151.85 | 112.02 | 92.60 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 3.75 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 19.68 | 20.27 | 15.80 | 9.34 | 6.58 | |
| Long Term Provisions | 0.00 | 0.11 | 0.00 | 1.45 | 1.14 | |
| Total Non-Current Liabilities | 19.68 | 20.38 | 15.80 | 10.79 | 11.47 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.01 | 0.00 | 0.00 | 14.17 | |
| Trade Payables | 32.81 | 31.81 | 28.08 | 21.65 | 15.55 | |
| Other Current Liabilities | 58.45 | 50.27 | 42.05 | 7.03 | 19.18 | |
| Short Term Provisions | 19.01 | 13.03 | 14.34 | 18.87 | 11.53 | |
| Total Current Liabilities | 110.26 | 95.13 | 84.47 | 47.55 | 60.43 | |
| Total Capital And Liabilities | 449.18 | 331.31 | 252.12 | 170.37 | 164.50 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 86.38 | 73.02 | 69.16 | 66.79 | 66.29 | |
| Intangible Assets | 32.65 | 40.76 | 21.85 | 17.09 | 20.33 | |
| Capital Work-In-Progress | 0.95 | 0.17 | 0.52 | 0.40 | 0.03 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 119.97 | 113.95 | 91.53 | 90.10 | 86.65 | |
| Non-Current Investments | 11.44 | 11.44 | 29.95 | 17.92 | 17.92 | |
| Deferred Tax Assets [Net] | 25.10 | 19.49 | 12.44 | 2.44 | 2.04 | |
| Long Term Loans And Advances | 13.65 | 18.42 | 8.38 | 16.52 | 9.92 | |
| Other Non-Current Assets | 3.15 | 2.36 | 2.22 | 2.27 | 1.48 | |
| Total Non-Current Assets | 173.31 | 165.65 | 144.52 | 129.26 | 118.02 | |
| CURRENT ASSETS | ||||||
| Current Investments | 37.92 | 8.59 | 50.32 | 4.76 | 1.00 | |
| Inventories | 13.70 | 11.02 | 7.89 | 5.61 | 7.22 | |
| Trade Receivables | 29.45 | 23.94 | 19.28 | 13.98 | 9.67 | |
| Cash And Cash Equivalents | 145.13 | 103.22 | 16.18 | 9.20 | 20.52 | |
| Short Term Loans And Advances | 45.20 | 15.61 | 13.85 | 7.39 | 7.52 | |
| OtherCurrentAssets | 4.46 | 3.29 | 0.10 | 0.18 | 0.56 | |
| Total Current Assets | 275.87 | 165.66 | 107.60 | 41.11 | 46.48 | |
| Total Assets | 449.18 | 331.31 | 252.12 | 170.37 | 164.50 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 11.48 | 13.45 | 8.77 | 11.50 | 2.37 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 1.77 | 1.79 | 0.61 | 0.94 | 0.35 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 2.03 | 4.54 | 0.41 | 2.44 | 1.68 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 4.20 | 4.78 | 2.54 | 7.06 | 5.31 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 1.99 | 1.90 | 1.96 | 1.42 | 0.79 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 50.32 | 50.32 | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 11.44 | 11.44 | 29.95 | 17.92 | 17.92 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | 37.92 | 8.59 | 50.32 | 4.76 | 1.00 |
05.12.2025
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak